Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Search content at Fujita Health University
Home
Profiles
Research units
Research output
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
Nobuki Hayakawa
,
Atsushi Suzuki
Department of Endocrinology, Diabetes and Metabolism
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of '[Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glucocorticoid-induced Osteoporosis
100%
Secondary Osteoporosis
100%
Glucocorticoid Therapy
25%
Primary Osteoporosis
12%
Denosumab
12%
Low Bone Mass
12%
Bone Anabolic Effects
12%
Alternative Therapy
12%
Fracture Risk
12%
Anabolic Therapy
12%
Postmenopausal Osteoporosis
12%
Antireceptor
12%
PTH(1-34)
12%
First-line Drugs
12%
Receptor Activator of nuclear factor-B Ligand
12%
Vertebral Fracture Risk
12%
Pharmacology, Toxicology and Pharmaceutical Science
Secondary Osteoporosis
100%
Postmenopause Osteoporosis
9%
Primary Osteoporosis
9%
Anabolic Steroid
9%
Denosumab
9%